PMID: 2484701Jan 1, 1989Paper

Oxygen and oxidation promote the release of nitric oxide from sydnonimines

Journal of Cardiovascular Pharmacology
H Bohn, K Schönafinger

Abstract

The antianginal effect of sydnonimines is believed to be due to the release of nitric oxide (NO) from inactive prodrugs. The first step in the transformation of the sydnonimine SIN-1 is the hydroxyl ion-dependent conversion to SIN-1A that occurs almost immediately at neutral pH. However, the subsequent process of NO release from SIN-1A is not yet understood. Therefore, the spontaneous degradation of SIN-1A in aqueous solutions was studied by chemical and pharmacological means. Measurement of the oxygen content of a freshly prepared SIN-1A solution revealed a rapid decrease of the oxygen concentration. The oxygen-consuming process was accompanied by a decrease in SIN-1A concentration and a progressive formation of NO and SIN-1C. SIN-1A was stable under nitrogen, labile under air, and very unstable under pure oxygen. Thus, oxygen is an important reactant in the decomposition of SIN-1A. The question of whether or not oxygen is essential for NO release was studied by investigating the effect of other oxidants. The oxidants potassium hexacyanoferrate, cupric sulfate, and lead tetraacetate augmented the conversion of SIN-1A to SIN-1C and increased the relaxing effect on isolated pulmonary arteries used to bioassay NO. Therefore, an o...Continue Reading

Citations

May 24, 2007·Basic Research in Cardiology·Solange C GarciaJochen D Schipke
Aug 3, 2010·Cell Biochemistry and Biophysics·Grigory G MartinovichHeinrich Sauer
Jul 24, 2002·Biochemical and Biophysical Research Communications·Teh-Min HuSusan R Mallery
Mar 7, 1998·British Journal of Pharmacology·S P OlesenA Mülsch
Jan 13, 2001·British Journal of Pharmacology·K E Wiley, A P Davenport
Mar 1, 1992·British Journal of Clinical Pharmacology·H SinzingerP Fitscha
Apr 1, 1995·British Journal of Pharmacology·H BohnK Schönafinger
Jun 27, 2013·Indian Journal of Pharmaceutical Sciences·S R DeshpandeK V Pai
Oct 27, 2007·Experimental Eye Research·Foteini KiagiadakiKyriaki Thermos
Mar 1, 1995·Cancer Treatment Reviews·S M SagarA C Whitton
Feb 7, 2006·Analytical Biochemistry·Douglas A RichardsAdam J Devall
Jan 1, 1994·Medicinal Research Reviews·J F Kerwin, M Heller
Jul 1, 1997·Biulleten' eksperimental'noĭ biologii i meditsiny·S V ZhuĭkovaI P Ashmarin
Feb 21, 2019·Physical Chemistry Chemical Physics : PCCP·Simon Mathieu, Georges Trinquier
Apr 7, 1997·FEBS Letters·T UllrichH Schröder

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.